Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

(2011) Stephen Sawcer et al.   NATURE

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

(2011) François Piette et al.   Alzheimers Research & Therapy

Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study

(2010) Carle Paul et al.   AMERICAN JOURNAL OF HEMATOLOGY

Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics

(2009) M. Humbert et al.   ALLERGY

Human Mast Cells Stimulate Activated T Cells

(2009) Theoharis C. Theoharides et al.   Annals of the New York Academy of Sciences

Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT

(2009) Patrice Dubreuil et al.   PLoS One

Progressive multiple sclerosis

(2009) Monika Bradl et al.   Seminars in Immunopathology

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

(2009) Jacques Tebib et al.   ARTHRITIS RESEARCH & THERAPY

Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma

(2008) Nandini Krishnamoorthy et al.   NATURE MEDICINE

Brain mast cells link the immune system to anxiety-like behavior

(2008) K. M. Nautiyal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA